Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis

Jie Shen,* Zhen Chen,* Min Fan, Hao Lu, Qianfeng Zhuang, Xiaozhou HeDepartment of Urology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, People’s Republic of China*These authors contributed equally to this work Background: In recent years, inflammation has become w...

Full description

Bibliographic Details
Main Authors: Shen J, Chen Z, Fan M, Lu H, Zhuang Q, He X
Format: Article
Language:English
Published: Dove Medical Press 2019-06-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/prognostic-value-of-pretreatment-neutrophil-count-in-metastatic-renal--peer-reviewed-article-CMAR
_version_ 1811230369585823744
author Shen J
Chen Z
Fan M
Lu H
Zhuang Q
He X
author_facet Shen J
Chen Z
Fan M
Lu H
Zhuang Q
He X
author_sort Shen J
collection DOAJ
description Jie Shen,* Zhen Chen,* Min Fan, Hao Lu, Qianfeng Zhuang, Xiaozhou HeDepartment of Urology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, People’s Republic of China*These authors contributed equally to this work Background: In recent years, inflammation has become widely recognized as a crucial component in tumor development and progression. Neutrophils are one of the most common inflammatory markers during hematological examinations. The prognostic value of neutrophils in metastatic renal cell carcinoma (mRCC) remains inconsistent. The aim of this meta-analysis is to evaluate the prognostic value of pretreatment neutrophil count in patients with mRCC.Methods: PubMed, Web of Science and Embase were searched for data on the association between pretreatment neutrophil count and mRCC prognosis up to October 7, 2017. We sorted out relevant studies and extracted the hazard ratio (HR) and its 95% confidence interval (CI) for overall survival (OS) and progression-free survival (PFS).Results: A total of 13 studies containing 3,021 patients with mRCC were summarized in the present meta-analysis. An elevated pretreatment neutrophil count yielded a worse OS (HR=2.17, 95% CI=1.68–2.79, P<0.001) and PFS (HR=1.78, 95% CI=0.91–3.49, P<0.001). Furthermore, we performed a subgroup analysis based on cut-off value, ethnicity, treatment method and analysis type. As a result, the association between pretreatment neutrophil count and survival was statistically significant in the subgroups of cut-off value, ethnicity, treatment method and analysis type.Conclusion: Our results show that the pretreatment neutrophil count is associated with mRCC outcomes and can be used as a valuable inflammatory marker for prognosis monitoring.Keywords: neutrophils, clear-cell metastatic renal cell carcinoma, prognosis, meta-analysis  
first_indexed 2024-04-12T10:28:20Z
format Article
id doaj.art-713af0cbad0a449091c79cd1ad54cb8a
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-04-12T10:28:20Z
publishDate 2019-06-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-713af0cbad0a449091c79cd1ad54cb8a2022-12-22T03:36:55ZengDove Medical PressCancer Management and Research1179-13222019-06-01Volume 115365537446373Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysisShen JChen ZFan MLu HZhuang QHe XJie Shen,* Zhen Chen,* Min Fan, Hao Lu, Qianfeng Zhuang, Xiaozhou HeDepartment of Urology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, People’s Republic of China*These authors contributed equally to this work Background: In recent years, inflammation has become widely recognized as a crucial component in tumor development and progression. Neutrophils are one of the most common inflammatory markers during hematological examinations. The prognostic value of neutrophils in metastatic renal cell carcinoma (mRCC) remains inconsistent. The aim of this meta-analysis is to evaluate the prognostic value of pretreatment neutrophil count in patients with mRCC.Methods: PubMed, Web of Science and Embase were searched for data on the association between pretreatment neutrophil count and mRCC prognosis up to October 7, 2017. We sorted out relevant studies and extracted the hazard ratio (HR) and its 95% confidence interval (CI) for overall survival (OS) and progression-free survival (PFS).Results: A total of 13 studies containing 3,021 patients with mRCC were summarized in the present meta-analysis. An elevated pretreatment neutrophil count yielded a worse OS (HR=2.17, 95% CI=1.68–2.79, P<0.001) and PFS (HR=1.78, 95% CI=0.91–3.49, P<0.001). Furthermore, we performed a subgroup analysis based on cut-off value, ethnicity, treatment method and analysis type. As a result, the association between pretreatment neutrophil count and survival was statistically significant in the subgroups of cut-off value, ethnicity, treatment method and analysis type.Conclusion: Our results show that the pretreatment neutrophil count is associated with mRCC outcomes and can be used as a valuable inflammatory marker for prognosis monitoring.Keywords: neutrophils, clear-cell metastatic renal cell carcinoma, prognosis, meta-analysis  https://www.dovepress.com/prognostic-value-of-pretreatment-neutrophil-count-in-metastatic-renal--peer-reviewed-article-CMARNeutrophilsClear-cell metastatic renal cell carcinomaPrognosisMeta-analysis
spellingShingle Shen J
Chen Z
Fan M
Lu H
Zhuang Q
He X
Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis
Cancer Management and Research
Neutrophils
Clear-cell metastatic renal cell carcinoma
Prognosis
Meta-analysis
title Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis
title_full Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis
title_fullStr Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis
title_full_unstemmed Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis
title_short Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis
title_sort prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma a systematic review and meta analysis
topic Neutrophils
Clear-cell metastatic renal cell carcinoma
Prognosis
Meta-analysis
url https://www.dovepress.com/prognostic-value-of-pretreatment-neutrophil-count-in-metastatic-renal--peer-reviewed-article-CMAR
work_keys_str_mv AT shenj prognosticvalueofpretreatmentneutrophilcountinmetastaticrenalcellcarcinomaasystematicreviewandmetaanalysis
AT chenz prognosticvalueofpretreatmentneutrophilcountinmetastaticrenalcellcarcinomaasystematicreviewandmetaanalysis
AT fanm prognosticvalueofpretreatmentneutrophilcountinmetastaticrenalcellcarcinomaasystematicreviewandmetaanalysis
AT luh prognosticvalueofpretreatmentneutrophilcountinmetastaticrenalcellcarcinomaasystematicreviewandmetaanalysis
AT zhuangq prognosticvalueofpretreatmentneutrophilcountinmetastaticrenalcellcarcinomaasystematicreviewandmetaanalysis
AT hex prognosticvalueofpretreatmentneutrophilcountinmetastaticrenalcellcarcinomaasystematicreviewandmetaanalysis